CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Taiwan Advance Bio-Pharmaceutical Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Taiwan Advance Bio-Pharmaceutical Inc
12F, No. 25
Lane 169, Kangning Street,Xizhi District
Phone: +886 226926222p:+886 226926222 NEW TAIPEI, 106  Taiwan Ticker: 41864186
Business Summary
Taiwan Advance Bio-Pharmaceutical Inc. is a Taiwan-based company principally engaged in the research, development, production and sales of drug residue test reagents. The Company is also involved in drug abuse testing business, the development and storage of cord blood stem cells, as well as the provision of biotechnology services. The Company operates its businesses in domestic market and overseas markets, such as the rest areas of Asia and Europe.
(Source: F-4)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
6/30/202412/31/2023Yes----

Industries
SIC Code Description
2836 Biological products, except diagnostic substances
8731 Commercial physical and biological research
8734 Testing laboratories

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board, General Manager WenlongSu
Deputy General Manager, Director YaocongChen 6/22/2020 6/22/2020
Deputy General Manager, Director ZhejiaLiu 6/19/2023 1/1/2022
6 additional Officers and Directors records available in full report.

General Information
Number of Employees: 154 (As of 12/31/2023)
Outstanding Shares: 90,000,000 (As of 6/30/2024)
Shareholders: 5,521
Stock Exchange: TPO
Fax Number: +886 226926229


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, November 22, 2024